oral glp 1 weight loss GLP-1 Pill Delivers Injection-Like Results in Clinical Trials TRC - New oral GLP-1s

Quick Answer: GLP-1 receptor agonists produce significant reductions in abdominal fat and waist circumference as part of generalized weight loss, though they do not selectively target belly fat

Mechanism underlying the weight loss and complications of Roux-en-Y gastric bypass

The general consensus, as highlighted in the recent consensus statement from the Association of Anaesthetists (9th January 2025), is that, with proper risk assessment and planning, these medications do not have to be stopped before surgery

The results, despite optimistic interpretation by the sponsors, showed little if any cardiovascular benefit that could not have been a consequence of glucose lowering with some suggestion that the net effects of some agents might be harmful on vascular disease (6)

Discontinuation rates due to adverse events were higher in the active treatment groups compared with placebo, particularly at higher doses, though the overall discontinuation rate remained relatively modest